ICLR
Icon PLC
$167.72
-1.05 (-0.62%)
At close · Jul 10
Market Cap
$13.01B
Shares
77,145,378
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$167.72
Open$168.77
Day$167.71–170.00
52W$66.57–211.00
Avg vol 30d1.1M
Short int3.0M · 3.9% float · 2.4d
Short vol37%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+12%
above
Price vs 50-day avg
+20%
above
RSI (14)
62
neutral
MACD trend
Negative
52-week position
70%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+16%
trailing
6-month return
−8%
trailing
YTD return
−8%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $140 › 200d $149 — 200d above 50d
Institutional flow
Accumulating
16 of 421 funds reported for Jun 30 · net +9.4K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.88% of float · ▼ -7.7% MoM · 2.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
421 holders — near 3-yr low, contrarian setup
Squeeze score
57
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
EPS growth
−67%
Y/Y
Free cash flow
$862.0M
Valuation
P/E 74.3
rich
Buyback
$750.0M
remaining
Balance sheet
$3.2B
net debt
Quant / Vol
risk profile
Volatility
71%
annualized · 1-yr
Max drawdown
−61%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+12%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
62
Neutral
MACD trend
Negative
Bearish
52-week position
70%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $140 › 200d $149 — 200d above 50d
Institutional flow
Accumulating
16 of 421 funds reported for Jun 30 · net +9.4K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.88% of float · ▼ -7.7% MoM · 2.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
421 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $67
Now $168 · 70%
52-wk high $211
vs 200-day avg +12%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ICLR
this stock
Icon PLC
|
$13.01B | -8.0% | +5.1% | 74.3 | 3.9% |
|
TMO
Thermo Fisher Scientific Inc.
|
$195.86B | -9.0% | +0.4% | 29.0 | 1.4% |
|
DHR
Danaher Corp /De/
|
$138.71B | -12.7% | +8.5% | 37.8 | 1.5% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.46B | -16.7% | +10.4% | 41.5 | 2.5% |
|
NTRA
Natera, Inc.
|
$40.37B | +17.8% | -2.8% | — | 4.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ICLR | -3.1% | +16.0% | -8.1% | -3.5% | -8.0% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -4.5% | +11.9% | -17.2% | -4.6% | -18.7% |
Capital returns
Buyback programs
· 4 active
· as of Mar 31, 2026
Authorized (total)
$2.50B
Spent (derived)
$1.75B
Remaining
$750.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1060955
CUSIP
G4705A100
13F (30d)
26 filings
17 filers
Visit website
Investor relations